Market Overview

UPDATE: Stifel Nicolaus Initiates IDEXX Laboratories at Hold on Valuation, Market Share Risk

Related IDXX
Earnings Scheduled For January 29, 2016
Worst Performing Industries For October 28, 2015

Stifel Nicolaus initiated coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Hold rating.

Stifel Nicolaus commented, "IDEXX's dominance in what has proven to be a relatively resilient vet market is likely to continue. That said, we believe this is already reflected in the stock's premium valuation. In addition, our work uncovers some headwinds that may strengthen as we enter 2013, notably, future chemistry share losses and an unfavorable change in the distributor landscape."

IDEXX Laboratories closed at $93.89 on Wednesday.

Latest Ratings for IDXX

Feb 2016Credit SuisseInitiates Coverage onOutperform
Aug 2015Raymond JamesDowngradesOutperformMarket Perform
Jul 2015Feltl & Co.UpgradesSellHold

View More Analyst Ratings for IDXX
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (IDXX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters